نتائج البحث

PRPS2-mediated modulation of the antitumor immune response in lung cancer through CCL2-mediated tumor-associated macrophages and myeloid-derived suppressor cells.

• Authors : Liu Q; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China.

Subjects: Chemokine CCL2*/Chemokine CCL2*/Chemokine CCL2*/metabolism ; Chemokine CCL2*/Chemokine CCL2*/Chemokine CCL2*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/immunology

• Source: Thoracic cancer [Thorac Cancer] 2024 Aug; Vol. 15 (23), pp. 1739-1748. Date of Electronic Publication: 2024 Jul 01.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells

• Authors : Qing Liu; Ningzi Wu; Peifeng Hou

Subjects: CCL2; lung cancer; macrophages

• Source: Thoracic Cancer, Vol 15, Iss 23, Pp 1739-1748 (2024)

تفاصيل العنوان

Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

• Authors : Wang C; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/pathology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Myeloid-Derived Suppressor Cells*/Myeloid-Derived Suppressor Cells*/Myeloid-Derived Suppressor Cells*/metabolism

• Source: Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (19), pp. 1843-1856. Date of Electronic Publication: 2023 May 23.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment

• Authors : Chao Wang; Kailun Fei; Lihui Liu

Subjects: EGFR; lung cancer; MDSC

• Source: Thoracic Cancer, Vol 14, Iss 19, Pp 1843-1856 (2023)

تفاصيل العنوان

Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer.

• Authors : Yuan, Meng; Zhai, Yirui; Men, Yu

Subjects: FLOW cytometry; IMMUNE checkpoint inhibitors; ANIMAL experimentation

• Source: Thoracic Cancer; Dec2022, Vol. 13 Issue 23, p3331-3340, 10p

تفاصيل العنوان

The role of microbiota in esophageal squamous cell carcinoma: A review of the literature.

• Authors : Chiang, Hsueh‐Chien^1,2 (AUTHOR); Hughes, Michael^2,3,4 (AUTHOR); Chang, Wei‐Lun^1,2 (AUTHOR)

• Source: Thoracic Cancer. Oct2023, Vol. 14 Issue 28, p2821-2829. 9p.

تفاصيل العنوان

Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer.

• Authors : Kumata, Sakiko^1,2,3 (AUTHOR); Notsuda, Hirotsugu¹ (AUTHOR) ; Su, Mei‐Tzu^2,4 (AUTHOR)

• Source: Thoracic Cancer. 7/22/2023, Vol. 14 Issue 21, p2057-2068. 12p.

تفاصيل العنوان

Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer.

• Authors : Mendes, Ana Sofia¹ ; Romão, Raquel¹; Febra, Joana¹

• Source: Thoracic Cancer. Feb2023, Vol. 14 Issue 5, p437-441. 5p.

تفاصيل العنوان

Autologous cytokine‐induced killer (CIK) cells enhance the clinical response to PD‐1 blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary study.

• Authors : Han, Ying^1,2,3,4 (AUTHOR); Mu, Di^1,2,3,4 (AUTHOR); Liu, Ting^2,3,4,5 (AUTHOR)

• Source: Thoracic Cancer. Jan2021, Vol. 12 Issue 2, p145-152. 8p.

تفاصيل العنوان

Compromise or not? A case report of successful treatment of pembrolizumab‐induced hepatitis in a patient with non‐small cell lung cancer with low‐dose methylprednisolone and bicyclol.

• Authors : Liu, Yan'e¹ (AUTHOR); Zhang, Jie^2,3 (AUTHOR); Yin, Zhongnan^2,3 (AUTHOR)

• Source: Thoracic Cancer. Jul2020, Vol. 11 Issue 7, p2023-2030. 8p.

تفاصيل العنوان